Toxic and side effects
Showing 1 - 25 of >10,000
Breast Cancer Trial in Columbus (MIND Diet Intervention Group, General Health Curriculum (GHC) Group)
Recruiting
- Breast Cancer
- MIND Diet Intervention Group
- General Health Curriculum (GHC) Group
-
Columbus, OhioThe Ohio State University
Aug 2, 2023
GHB Poisoning and Poisoning Induced by Others
Recruiting
- Drug Toxicity
-
Oslo, NorwayUniversity of Oslo, Institute of Health and Society
Nov 8, 2022
Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
Unknown status
- Stevens-Johnson Syndrome
- +2 more
- Site specific standard of care comparison
- (no location specified)
Dec 1, 2020
Ovary Cancer, Endometrial Cancer, Uterine Cancer Trial in Chicago (FAST Intervention)
Not yet recruiting
- Ovary Cancer
- +2 more
- FAST Intervention
-
Chicago, IllinoisNorthwestern Memorial Hospital
Aug 4, 2023
Lung Cancer Trial in Shanghai (chemo plus TCM 1&ICIs plusTCM2 , chemo plus TCM 1 &ICIs plus TCM2 )
Not yet recruiting
- Lung Cancer
- chemotherapy plus TCM 1&ICIs plusTCM2 placebo
- chemotherapy plus TCM 1placebo &ICIs plus TCM2 placebo
-
Shanghai, Shanghai, ChinaYueYang Hosptial of Intergrated Traditional Chinese and Western
Apr 17, 2023
Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)
Enrolling by invitation
- Esophageal Carcinoma
- Nimotuzumab
- +2 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
Retroperitoneal Fibrosis Trial in Beijing (Sirolimus, Corticosteroid)
Recruiting
- Retroperitoneal Fibrosis
-
Beijing, Beijing, ChinaPeking University International Hospital
Dec 7, 2022
Colorectal Cancer, Colorectal Tumors Malignant, Intestinal Tumors, Malignant Trial in Shanghai (Ileostomy, Transverse colostomy)
Recruiting
- Colorectal Cancer
- +2 more
- Ileostomy
- Transverse colostomy
-
Shanghai, ChinaFudan University Shanghai Cancer Center
May 2, 2023
Locally Advanced Pancreatic Cancer Trial (Stereotactic body radiation(SBRT), Zimberelimab (GLS-010))
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Stereotactic body radiation(SBRT)
- Zimberelimab (GLS-010)
- (no location specified)
Aug 22, 2023
Recurrent Glioblastoma Trial in Beijing (Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous
Not yet recruiting
- Recurrent Glioblastoma
- Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes.
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Oct 10, 2022
Esophageal Squamous Cell Carcinoma, Chemo Effect, Side Effect of Drug Trial in Nanjing (Consolidation chemo (4 courses),
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
- Consolidation chemotherapy (4 courses)
- Concurrent chemotherapy (2 courses)
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Mar 16, 2023
Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)
Terminated
- Neuroblastoma
- antibody ch14.18
- +4 more
-
Cologne, GermanyUniversity of Cologne
Nov 3, 2022
Sterile Corneal Melt Trial in Montreal (Topical Infliximab)
Recruiting
- Sterile Corneal Melt
- Topical Infliximab
-
Montreal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Dec 12, 2022
Cirrhotic Patients With and Without Hepatocellular Carcinoma
Not yet recruiting
- Pulmonary Complications of Liver Cirrhosis and HCC
- spirometry
-
Sohag, EgyptSohag University hospitals
Jul 26, 2023
HER2-positive Breast Cancer Trial in Guanzhou (Eribulin mesylate injection?Pertuzumab?Trastuzumab)
Recruiting
- HER2-positive Breast Cancer
- Eribulin mesylate injection、Pertuzumab、Trastuzumab
-
Guanzhou, Guangdong, ChinaLI YuDong
Jul 13, 2023
Drug Antibody and Precision Transfusion in China
Recruiting
- Drug-specific Antibodies
-
Guangzhou, Gaungdong, ChinaNanfang hospital of southern medical university
Nov 2, 2022
Chordoma Trial in Houston (Proton Beam Therapy, Photon Beam Therapy)
Active, not recruiting
- Chordoma
- Proton Beam Therapy
- Photon Beam Therapy
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet
Recruiting
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 22, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma Stage I
- Medroxyprogesterone acetate + Atorvastatin
-
Peking, Beijing, ChinaWang Jianliu
Dec 29, 2022
Insomnia, Perimenopause Trial in Hefei (Traditional Chinese Medicine auricular acupuncture point buried seeds therapy plus the
Completed
- Insomnia
- Perimenopause
- Traditional Chinese Medicine auricular acupuncture point buried seeds therapy plus the fire dragon pot moxibustion therapy.
- Traditional Chinese Medicine auricular acupuncture point buried seeds therapy
-
Hefei, Anhui, ChinaThe Third Affiliated Hospital of Anhui Medical University (The f
Feb 8, 2022
Cytomegalovirus Retinitis, HIV Trial (Foscarnet sodium)
Withdrawn
- Cytomegalovirus Retinitis
- HIV Infections
- Foscarnet sodium
- (no location specified)
Oct 27, 2021
Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)
Not yet recruiting
- Liver Metastasis Colon Cancer
- TACE and HAIC Combined With Regorafenib
-
Guangzhou, Guangdong, Chinathe first affiliated hospital, Sun-Yat sen university
Oct 2, 2023
Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Advanced Solid Tumor
- Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
- Tegafur Only Product
-
Petaling Jaya, Kuala Lumpur, MalaysiaClinical Oncology Department, Ummc
Jul 12, 2023
Ovarian Cancer Trial in Guangzhou (Pamiparib/Tamoxifen)
Not yet recruiting
- Ovarian Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Centre
Dec 30, 2022